UnitedHealth Group Projected to Boost Medicare Advantage Ratings

UnitedHealth Group Incorporated (UNH) recently raised its outlook by 8.6%, expressing confidence in its Medicare Advantage (MA) star ratings. A strong rating translates to better financial rewards for insurers.

The company expects that by next year, about 78% of MA members will be enrolled in plans rated 4 stars or higher. This target was initially set by former CEO Andrew Whitty earlier this summer and aligns with their historical performance.

Medicare Advantage, which is federally funded and administered through private insurers, has faced increasing challenges as older adults utilize more health services, leading to higher costs and tighter margins. Nevertheless, a recent survey by the Kaiser Family Foundation suggests that by 2025, CMS plans to distribute $12.7 billion in bonuses for Medicare Advantage, an increase from the $11.8 billion allocated in 2024.

UnitedHealth is maintaining its projected adjusted earnings per share (EPS) of $16 for 2025, a forecast updated on July 29. The company is currently examining Medicare claims, reimbursement structures, and the operations of Optum RX’s pharmacy benefit management services. Additionally, following the cyberattacks on the healthcare system in 2024, there are ongoing discussions about the firm’s loan policies to healthcare providers, with some lawmakers expressing concerns about the company’s repayment strategies.

Alongside UnitedHealth, both CVS Health Corporation (CVS) and Centene Corporation (CNC) saw their stock prices increase yesterday. The companies discussed the benefits of Medicare, driven by a positive outlook for the industry. However, there are reports indicating that the criteria for bonus eligibility, referred to as “cut points,” are becoming harder to meet. Humana Inc. (HUM) experienced a significant drop of 12% over concerns regarding its ability to reach these stringent benchmarks, highlighting the close relationship between Medicare star ratings and the profitability of major insurers. A definitive assessment from CMS is anticipated in October.

With recent gains in stock value, UNH’s decline since the beginning of the year has lessened to 31.2%, whereas the overall industry drop stands at 28.9%.

From a valuation standpoint, UnitedHealth is currently trading at a price-to-earnings (P/E) ratio of 20.33, compared to an industry average of 15.38. The company holds a value score of C.